Poland· PL-100507398
Thyrozol
A thiamazole product containing thiamazolum, registered in Poland by Allpharm Sp. z o.o. sp.k.. The same ATC class is registered in 12 of our 19 countries.
Checked against URPL (Poland) on
Informational only — not a medical device.
Where it is registered
Thiamazole is registered in 12 of 19 countries.
Countries holding a registration under ATC H03BB02 (thiamazole), each read from that country’s own register.
- This record: Poland, from URPL (Poland)
- 6 of them publish a price we can compare per daily dose
Thiamazole · ATC H03BB02
12 / 19 countries
- Belgiumprice
- Canada
- Czechiaprice
- Denmark
- Finlandprice
- Franceprice
- Germany
- Icelandprice
- Netherlands
- Polandprice
- Sweden
- United Kingdom
Price per daily dose
What a daily dose of thiamazole costs, country by country.
Normalised to the WHO defined daily dose (10 mg), so markets compare like for like.
- 1 market with a comparable price for this class
- Public list prices, converted to USD at the rate date shown
Thiamazole · price per daily dose (10 mg)
USD · FX 28 Sept 2026
- FR France$0.12
The record
At a glance
URPL (Poland)- Active substance
- Thiamazolum
- Manufacturer
- Allpharm Sp. z o.o. sp.k.
- Country
- Poland (PL)
- ATC code
- H03BB02
- ATC class
- Thiamazole
- Defined daily dose
- 10 mg, O
- Reimbursed
- Not published by this register
- Source register
- URPL (Poland)
- Last checked
- September 27, 2026
Packs & prices · 4
- gtin05909991557171
- gtin05909991557188
- gtin05909991557195
- gtin05909991557201
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Interactions
170 interactions on record for thiamazole.
Graded by severity as the source publishes them — 10 severe. Severity grades are free for everyone; mechanism and management come with Growth.
- Severity for every pair — free, no plan needed
- The source, licence and sync date on every record
- Mechanism and what to do for each pair — Growth plan
Thiamazole · interactions on record
170 records
- 10 severe
- 42 moderate
- 2 minor
- 116 info
Most severe, free to view
- MipomersenC10AX11severe
- LomitapideC10AX12severe
- PexidartinibL01EX15severe
- LeflunomidL04AA13severe
- Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Same medicine, other countries
Thiamazole in 13 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- CzechiaTHYROZOLMERCK spol. s r.o., Praha
- FranceTHYROZOL 10 mg, comprimé pelliculé sécableMERCK SANTE
- United StatesmethimazoleSQUARE PHARMACEUTICALS PLC.
- FinlandApelka VetNorbrook Laboratories (Ireland) Limited
- CanadaFELIMAZOLE 1.25 MGDECHRA LTD
- GermanyMethizol SdMibe Gmbh Arzneimittel
- NetherlandsStrumazol 10 mg, tablettenEuro Registratie Collectief B.V.
- SwedenThacapzol 5 mg TablettViatris AB
Authorised across Europe · EMA
The same active substance is authorised in 24 EEA countries. Names it is sold under:
- Austria · Thiamazol Sandoz
- Belgium · Strumazol
- Bulgaria · Метизол, Тирозол
- Cyprus · Unimazole
- Czechia · Thyrozol
- Germany · Methizol Sd, Thiamazol
- Denmark · Thiamazole "uni-Pharma", Thycapzol
- Estonia · Thyrozol
- Spain · Tirodril
- France · Thiamazole Uni-Pharma, Thyrozol
- Greece · Unimazole
- Croatia · Athyrazol
- Hungary · Metothyrin
- Iceland · Thiamazole Uni-Pharma
- Italy · Tapazole
- Lithuania · Metizol, Thyrozol
- Luxembourg · Strumazol, Thyrozol
- Latvia · Thyrozol
- Netherlands · Strumazol
- Portugal · Metibasol
- Romania · Thyrozol
- Sweden · Thacapzol, Thiamazole Uni-Pharma
- Slovenia · Athyrazol
- Slovakia · Thyrozol
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of URPL (Poland). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/bbd1bfa6-9605-4932-881d-2d2f02f91bf4 GET /v1/drugs/bbd1bfa6-9605-4932-881d-2d2f02f91bf4?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"form": "Tabletki powlekane",
"source": "urpl",
"strength": "10 mg",
"packaging": "05909991557171 ¦ Rp ¦ 158563\n20 tabl.\n05909991557188 ¦ Rp ¦ 158564\n30 tabl.\n05909991557195 ¦ Rp ¦ 158565\n50 tabl.\n05909991557201 ¦ Rp ¦ 158566\n100 tabl.",
"substance": "Thiamazolum 10 mg",
"common_name": "Thiamazolum",
"pl_product_id": "100507398",
"pozwolenie_nr": "365/24",
"auth_procedure": "IR",
"authorisation_validity": "2029-10-17"
}See everything about thiamazole.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.